Copertina

Prescribing pattern of antipsychotics for patients with schizophrenia using the total daily dose online tool

This study aimed to investigate the prescribing pattern of antipsychotic medications for schizophrenia using the British National Formulary total daily dose (TDD) online tool. We analysed data from the electronic medical records at King Khalid University Hospital (KKUH) of 272 patients diagnosed wit...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Jawza F. Alsabhan (Autore), Haya M. Almalag (Autore), Lubna Aljafali (Autore), Hessa Alnughamish (Autore), Gaida Almutlaq (Autore)
Natura:	Libro
Pubblicazione:	Elsevier, 2023-12-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
di: Nina Vadiei, et al.
Pubblicazione: (2022)

New atypical antipsychotics for schizophrenia: iloperidone
di: Silvio Caccia, et al.
Pubblicazione: (2010)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
di: Xiaomei Peng, et al.
Pubblicazione: (2011)

A content-quality and optimization analysis of YouTube as a source of patient information for bipolar disorder
di: Jawza F. Alsabhan, et al.
Pubblicazione: (2024)

Antipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia
di: Ling-Ling Yeh, et al.
Pubblicazione: (2023)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
di: Norio Yasui‐Furukori, et al.
Pubblicazione: (2020)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
di: I. A. Vilyum, et al.
Pubblicazione: (2018)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
di: Hülya Ertekin, et al.
Pubblicazione: (2016)

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia
di: Jaballah Fares, et al.
Pubblicazione: (2023)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
di: Lally J, et al.
Pubblicazione: (2016)

The place of long-acting injectable antipsychotics in the treatment of schizophrenia
di: John M. Kane, et al.
Pubblicazione: (2023)

Long-acting antipsychotic treatments: focus on women with schizophrenia
di: Sofia Brissos, et al.
Pubblicazione: (2024)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
di: I. A. Vilyum, et al.
Pubblicazione: (2018)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
di: Kaitlyn Morgan, PharmD, BCPP, et al.
Pubblicazione: (2023)

Are antiretrovirals prescribed according to the recommended prescribed daily doses in the private healthcare sector in South Africa
di: Norah L. Katende-Kyenda, et al.
Pubblicazione: (2011)

Cognitive symptoms associated with antipsychotic course experience in residual schizophrenia
di: D. Safonov
Pubblicazione: (2021)

Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication
di: Elnaz Faramarzi, et al.
Pubblicazione: (2020)

Prescription of antipsychotics and prevalence of metabolic syndrome in Vietnamese inpatients with schizophrenia
di: Nguyen Thi Minh Thuan, et al.
Pubblicazione: (2022)

Factors associated with high‐dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture
di: Tatsuichiro Takahashi, et al.
Pubblicazione: (2020)

Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics
di: Ching-Hua Lin, et al.
Pubblicazione: (2022)

Antibiotic Consumption and Deviation of Prescribed Daily Dose From the Defined Daily Dose in Critical Care Patients: A Point-Prevalence Study
di: Patricia Helena Castro Nunes, et al.
Pubblicazione: (2022)

A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
di: Caccia S, et al.
Pubblicazione: (2013)

Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics
di: Shubhra Mace, et al.
Pubblicazione: (2019)

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects
di: Kaleen N. Hayes, et al.
Pubblicazione: (2021)

The Prevalence of and Documented Indications for Antipsychotic Prescribing in Irish Nursing Homes
di: Jayne E. Kelleher, et al.
Pubblicazione: (2021)

Acute overdose of antipsychotics and antidepressants by patient with paranoid schizophrenia - a case report
di: Anna Katarzyna Orzeł, et al.
Pubblicazione: (2019)

RELAPSE EPISODES OF SCHIZOPHRENIA IN PATIENTS TREATED WITH ANTIPSYCHOTIC MEDICATIONS IN MAIDUGURI: CAUSES AND INTERVENTIONS
di: OHIEKU JD, et al.
Pubblicazione: (2016)

Acute overdose of antipsychotics and antidepressants by patient with paranoid schizophrenia - a case report
di: Anna Katarzyna Orzeł, et al.
Pubblicazione: (2019)

Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications
di: Caiji Zheng, et al.
Pubblicazione: (2023)

Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
di: Joanna Moncrieff, et al.
Pubblicazione: (2020)

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
di: Raghunath Singh, et al.
Pubblicazione: (2022)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
di: O'Day K, et al.
Pubblicazione: (2013)

Prescribed daily-dose-based metrics of oral antibiotic use for hospitalized children in Japan
di: Wataru Mimura, et al.
Pubblicazione: (2023)

Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City
di: Ramiro Sánchez-Huesca, et al.
Pubblicazione: (2020)

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
di: Keqiang Wang, et al.
Pubblicazione: (2022)

Retrospective analysis of antipsychotic prescription models in correlation with symptoms of residual schizophrenia. Part 1
di: D. N. Safonov
Pubblicazione: (2020)

Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication
di: Ross Lawrenson, et al.
Pubblicazione: (2020)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
di: Maximilian Huhn, et al.
Pubblicazione: (2022)

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
di: Boonlue T, et al.
Pubblicazione: (2016)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
di: Anastasiia S. Boiko, et al.
Pubblicazione: (2021)